Vehicles, Chelators, and Radionuclides: Choosing the “Building Blocks” of an Effective Therapeutic Radioimmunoconjugate
- 1 January 1996
- journal article
- review article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 7 (2), 165-179
- https://doi.org/10.1021/bc950097s
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Metal carbonyl syntheses XXII. Low pressure carbonylation of [MOCl4]− and [MO4]−: the technetium(I) and rhenium(I) complexes [NEt4]2[MCl3(CO)3]Journal of Organometallic Chemistry, 1995
- Facile synthesis of homogeneous artificial proteinsJournal of the American Chemical Society, 1994
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Radionuclide therapy of cancerNuclear Medicine Communications, 1993
- An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acidBioconjugate Chemistry, 1992
- Radionuclide therapy revisitedEuropean Journal of Nuclear Medicine and Molecular Imaging, 1991
- Metal Complexes with Macrocyclic Ligands. Part XXXII. Reactivity studies of the pendant carboxylic group in a macrocyclic Cu2+ complex towards amide formation and its use as a protein‐labelling agentHelvetica Chimica Acta, 1990
- A novel derivative of the chelon desferrioxamine for site‐specific conjugation to antibodiesInternational Journal of Cancer, 1989
- Comparison of methods for the generation of immunoreactive fragments of a monoclonal antibody (B72.3) reactive with human carcinomasJournal of Immunological Methods, 1989
- Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.The Journal of Experimental Medicine, 1983